Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (8)

• <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
• Increasing trends in Deep Infiltrating Endometriosis (DIE) with Bilateral Endometrioma from Adolescence till Menopause: Case Series 2019
• Elevación de los marcadores de estrés oxidativo en pacientes con endometriosis. 2019
• Serum carcinogenic antigen (CA)-125 and CA 19-9 combining pain score in the diagnosis of pelvic endometriosis in infertile women 2016
• A Comparison of Treatment Modalities in 69 Patients with Endometriosis and/or Endometrioma and Review of the Literature 2015
• CA-125 concentration in serum and peritoneal fluid in patients with endometriosis – preliminary results 2012
• Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
• Abordagem da dor pélvica crônica em mulheres 2006

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00